New Key Statistics Module, Z-Score and F-Score
NAS:MRNA Key Ratios
| Market Cap $ M | 38,146.79 |
| Enterprise Value $ M | 32,111.75 |
| P/E(ttm) | 36.99 |
| PE Ratio without NRI | 36.99 |
| Forward PE Ratio | -- |
| Price/Book | 2.25 |
| Price/Sales | 3.96 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 10,523.00 |
| EPS (TTM) $ | 2.71 |
| Beneish M-Score | -3.1 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -92.80 |
| EV-to-EBIT | 37.43 |
| EV-to-EBITDA | 26.30 |
| PEG | -- |
| Shares Outstanding M | 380.59 |
| Net Margin (%) | 11.47 |
| Operating Margin % | 4.88 |
| Pre-tax Margin (%) | 7.77 |
| Quick Ratio | 3.16 |
| Current Ratio | 3.39 |
| ROA % (ttm) | 4.87 |
| ROE % (ttm) | 6.64 |
| ROIC % (ttm) | 5.07 |
| Dividend Yield % | -- |
| Altman Z-Score | 6.99 |
| Piotroski F-Score | 3.00 |
| Positive ROA | Y |
| Positive CFROA | N |
| Higher ROA y-y | N |
| Cash flow > Earnings | N |
| Lower Leverage y-y | N |
| Higher Current Ratio y-y | Y |
| Less Shares Outstanding y-y | Y |
| Gross Margin Increase y-y | N |
| Higher Asset Turnover y-y | N |
MRNA Number of Guru Trades
MRNA Volume of Guru Trades
Gurus Latest Trades with NAS:MRNA
No Available Data
NAS:MRNA is held by these investors
Total 5
Moderna Inc Insider Transactions
No Available Data
News about NAS:MRNA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers